Home/Recalls/FDA-D-0291-2026
FDA DrugsClass III

Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT ...

Published: January 28, 2026Recall ID: D-0291-2026Category: drugsCountry: US

Reason for Recall / Hazard

Failed PH Specifications

Product Description & Identification

Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215. NDC: 76282-103-39

Affected Products

Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215. NDC: 76282-103-39

Additional Source Details

FieldValue
CityWarren
StateNJ
Openfda › UniiQTG126297Q
Openfda › RouteTOPICAL
Openfda › Rxcui855633
Openfda › Spl id6fc74e92-7f37-41e7-aa8b-8fd0275a57c9
Openfda › Brand nameDICLOFENAC SODIUM
Openfda › Spl set idbe25c19e-cbea-4f87-a581-9f0d350e5adf
Openfda › Package ndc76282-103-39
Openfda › Product ndc76282-103
Openfda › Generic nameDICLOFENAC SODIUM
Openfda › Product typeHUMAN OTC DRUG
Openfda › Substance nameDICLOFENAC SODIUM
Openfda › Manufacturer nameEXELAN PHARMACEUTICALS INC.
Openfda › Application numberANDA209903
Openfda › Is original packagertrue
Event id98193
Address 110 Independence Blvd
Code infoBatch XHBG; Exp. 08/31/2027
Postal code07059-2730
Report date20260128
Product typeDrugs
Product quantity92,376 tubes
Reason for recallFailed PH Specifications
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20251222
Initial firm notificationLetter
Center classification date20260120

Overview

  • Recalling FirmCipla USA, Inc.
  • StatusOngoing
  • Risk LevelClass III
  • DistributionNationwide in the USA
Official Agency Alert